Today's Highlights
Premium
Gilead Sciences and Arcus Biosciences: Complete Closing of Option Exercises of 3 Programs. See Also: HOLD Put on Lenacapavir Due to Vial Quality Concern
Gilead Sciences and Arcus Biosciences Gilead Sciences ( GILD ) and Arcus Biosciences ( RCUS ) announced the closing of Gilead’s option exercises to three programs in Arcus’s clinical-stage portfolio a...
P
Prohost Biotech
1 min read
2
0
Unlock Premium Content
This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.
Unlimited articles
Expert analysis
Research reports
Comments (0)
Please sign in to join the discussion